Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-1997 | 12-1996 | 09-1996 | 06-1996 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 6,840 | 2,480 | 2,140 | 3,000 |
| Marketable Securities | 0 | 500 | 0 | 0 |
| Other current assets | 100 | 170 | 120 | 50 |
| TOTAL | $6,940 | $3,150 | $2,260 | $3,050 |
| Non-Current Assets | ||||
| PPE Net | 1,413 | 1,383 | 2,160 | 2,130 |
| Other Non-Current Assets | 1,570 | 1,580 | 1,720 | 1,610 |
| TOTAL | $2,983 | $2,963 | $3,880 | $3,740 |
| Total Assets | $9,490 | $5,720 | $5,290 | $5,990 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 0 | 0 | 8 | 0 |
| Accounts payable and accrued liabilities | 260 | 360 | 310 | 370 |
| Accrued Expenses | 80 | 190 | 30 | 10 |
| Other current liabilities | 0 | 6 | 60 | 80 |
| TOTAL | $360 | $580 | $420 | $470 |
| Non-Current Liabilities | ||||
| Long Term Debt | 0 | 0 | 10 | 0 |
| TOTAL | $20 | $20 | $10 | $N/A |
| Total Liabilities | $380 | $600 | $440 | $470 |
| Shareholders' Equity | ||||
| Common Shares | 110 | 100 | 100 | 100 |
| Retained earnings | -28,000 | -26,790 | -24,910 | -23,890 |
| Other shareholders' equity | -460 | -610 | -840 | -1,190 |
| TOTAL | $9,100 | $5,110 | $4,850 | $5,510 |
| Total Liabilities And Equity | $9,480 | $5,710 | $5,290 | $5,980 |